News | September 30, 2023
Menarini strengthens its presence in aesthetic dermatology in India
The introduction of 'Definisse Core Filler' is a testament to the company's premium scientific-based innovation
The introduction of 'Definisse Core Filler' is a testament to the company's premium scientific-based innovation
Lupin has been exclusively marketing these brands in the Indian market since July 2021
If approved, the vaccine could help simplify the meningococcal vaccination schedule and provide the broadest serogroup coverage of any meningococcal vaccine
Elacestrant, if approved, would be the first oral selective estrogen receptor degrader (SERD) to be available for patients suffering from second-line (2L) and third-line (3L) ER+/HER2- advanced or metastatic breast cancer in the European Union
Intended for potential treatment of ER+/HER2- advanced or metastatic breast cancer patients
The groundbreaking SPF technology is specifically designed and formulated to prevent sunburn or sun damage while allowing the passage of sufficient UVB light that our bodies use to naturally produce vitamin D
It provides Covid-19 detection and Omicron surveillance in less than two hours
Norepinephrine Bitartrate Injection is used for restoration of blood pressure in adult patients
Rs. 64000 crores are being invested across the 750 districts of India, to create a more resilient healthcare system in the country
This acquisition strengthens Lupin's commitment to providing superior treatment options for patients navigating the complexities of diabetes
Subscribe To Our Newsletter & Stay Updated
_256_275.jpg)